Rhenman & Partners Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Rhenman & Partners Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-23,400	Closed	-$187K	–	107
2017 Q2	$187K	Hold	23,400	–	–	0.03%	104
2017 Q1	$281K	Hold	23,400	–	–	0.04%	99
2016 Q4	$503K	Hold	23,400	–	–	0.1%	87
2016 Q3	$1.79M	Buy	23,400 +2,500	+12%	+$182K	0.28%	82
2016 Q2	$1.58M	Hold	20,900	–	–	0.28%	82
2016 Q1	$1.82M	Hold	20,900	–	–	0.36%	77
2015 Q4	$2.47M	Hold	20,900	–	–	0.37%	79
2015 Q3	$1.84M	Hold	20,900	–	–	0.29%	81
2015 Q2	$2.27M	Hold	20,900	–	–	0.27%	91
2015 Q1	$2.64M	Buy	20,900 +3,000	+17%	+$390K	0.44%	79
2014 Q4	$2.27M	Buy	+17,900	New	+$2.48M	0.66%	66

Other funds holding TNDM

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Rhenman & Partners Asset Management's TNDM Position: Q3 2017 in Review

Rhenman & Partners Asset Management sold out of Tandem Diabetes Care (TNDM) in Q3 2017, closing a stake of 23,400 shares — an estimated $187K sold.

Rhenman & Partners Asset Management first reported a position in TNDM in Q4 2014 and held it in 11 quarters. The position peaked at $2.64M in Q1 2015. 46 funds tracked by Wall St. Rank hold TNDM as of Q3 2017.

Rhenman & Partners Asset Management reported no remaining Tandem Diabetes Care position as of Q3 2017 after selling out during the quarter.
Rhenman & Partners Asset Management sold 23,400 Tandem Diabetes Care shares in Q3 2017, an estimated $187K.
Rhenman & Partners Asset Management first reported a position in Tandem Diabetes Care in Q4 2014 and held it in 11 quarters.
Rhenman & Partners Asset Management's Tandem Diabetes Care position peaked at $2.64M in Q1 2015.
46 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2017.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2017, filed 13 Oct 2017.